Advertisement
Australia markets closed

  • ALL ORDS

    7,837.40
    -100.10 (-1.26%)
     

  • ASX 200

    7,575.90
    -107.10 (-1.39%)
     

  • AUD/USD

    0.6545
    +0.0022 (+0.34%)
     

  • OIL

    84.26
    +0.69 (+0.83%)
     

  • GOLD

    2,354.90
    +12.40 (+0.53%)
     

  • Bitcoin AUD

    98,374.08
    +583.80 (+0.60%)
     

  • CMC Crypto 200

    1,388.98
    -7.56 (-0.54%)
     

  • AUD/EUR

    0.6101
    +0.0028 (+0.46%)
     

  • AUD/NZD

    1.0990
    +0.0032 (+0.30%)
     

  • NZX 50

    11,805.09
    -141.34 (-1.18%)
     

  • NASDAQ

    17,430.50
    -96.30 (-0.55%)
     

  • FTSE

    8,116.81
    +37.95 (+0.47%)
     

  • Dow Jones

    38,085.80
    -375.12 (-0.98%)
     

  • DAX

    18,055.39
    +138.11 (+0.77%)
     

  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

Pacific Biosciences of California, Inc. Third Quarter 2021 Financial Results Call

Pacific Biosciences of California, Inc.
·1-min read

MENLO PARK, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its third quarter 2021 financial results on Tuesday, November 2, 2021, at 4:30pm Eastern Time.

The call will be webcast and may be accessed at Pacific Biosciences’ website at: https://investor.pacificbiosciences.com/.

Date: Tuesday, November 2, 2021

Time: 4:30pm ET

Listen via Internet: https://investor.pacificbiosciences.com/

Toll-free: 888.366.7247

International: 707.287.9330

Conference ID: 5129207

Replay: https://investor.pacificbiosciences.com

ADVERTISEMENT

About Pacific Biosciences

Pacific Biosciences of California, Inc. (NASDAQ: PACB) is empowering life scientists with highly accurate long-read sequencing. The company’s innovative instruments are based on Single Molecule, Real-Time (SMRT®) Sequencing technology, which delivers a comprehensive view of genomes, transcriptomes, and epigenomes, enabling access to the full spectrum of genetic variation in any organism. Cited in thousands of peer-reviewed publications, PacBio® sequencing systems are in use by scientists around the world to drive discovery in human biomedical research, plant and animal sciences, and microbiology.

Contacts

Investors:
Todd Friedman
650.521.8450
ir@pacificbiosciences.com